Novo Nordisk has announced a collaboration with OpenAI aimed at enhancing the skills of its global workforce and boosting their proficiency in artificial intelligence. According to Jin10, this partnership is part of Novo Nordisk's broader strategy to integrate advanced AI capabilities into its operations, ensuring that employees are well-equipped to leverage these technologies effectively. The initiative underscores the growing importance of AI in the pharmaceutical industry, as companies seek to harness its potential to drive innovation and improve efficiency.